Pricing Log in Create free account
Friday 6 November 2026 Export IQV’s income statement to Excel — free account

IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.

Revenue
+8.00%
EPS
+10.2%
Free cash flow
−21.3%
Total debt
+7.42%

Quarter to September 2026, against a year earlier

271.68 6.80 +2.57%
Market cap
$43.7B
P/E
32.6×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

IQVIA Holdings Inc. 10-Q filed Jul 22, 2025

Fiscal Q2 2025 · Period ended Jun 30, 2025 · Filed · accepted 4:50 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed May 6, 2025: 13 added · 3 removed · 29 modified; 12 with only figures updated

  1. Modified · Overview

    IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected IntelligenceTM to deliver actionable insights and services built on high-quality health data, Healthcare-grade AITMAI®, advanced analytics, the latest technologies and extensive domain expertise. We are committed to using artificial intelligence ("AI") responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 89,00090,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, we are dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.